Huang Yuling, Li Xin, Yang Lina
Departments of Geriatrics, First Affiliated Hospital of China Medical University, Shenyang, China.
Departments of Infectious Disease, First Affiliated Hospital of China Medical University, Shenyang, China.
Front Bioeng Biotechnol. 2022 Apr 1;10:859927. doi: 10.3389/fbioe.2022.859927. eCollection 2022.
Biomaterials have long been the focus of research and hydrogels are representatives thereof. Hydrogels have attracted much attention in the medical sciences, especially as a candidate drug-carrier. Mesenchymal stem cells (MSC) and MSC-derived secretome are a promising therapeutic method, owing to the intrinsic therapeutic properties thereof. The low cell retention and poor survival rate of MSCs make further research difficult, which is a problem that hydrogel encapsulation largely solved. In this review, safety and feasibility of hydrogel-encapsulated MSCs, the improvement of the survival, retention, and targeting, and the enhancement of their therapeutic effect by hydrogels were studied. The status of the hydrogel-encapsulated MSC secretome was also discussed.
生物材料长期以来一直是研究的重点,水凝胶就是其中的代表。水凝胶在医学领域备受关注,尤其是作为一种候选药物载体。间充质干细胞(MSC)及其分泌组因其内在的治疗特性而成为一种有前景的治疗方法。MSC的低细胞保留率和低存活率给进一步研究带来困难,而水凝胶封装在很大程度上解决了这个问题。在这篇综述中,研究了水凝胶封装的MSC的安全性和可行性、其存活率、保留率和靶向性的改善,以及水凝胶对其治疗效果的增强作用。还讨论了水凝胶封装的MSC分泌组的研究现状。